MAIA — Maia Biotechnology Balance Sheet
0.000.00%
- $60.65m
- $51.05m
Annual balance sheet for Maia Biotechnology, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | PROSPECTUS/A | PROSPECTUS | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Short Term Investments | 0.663 | 10.6 | 11 | 7.15 | 9.6 |
Net Total Receivables | — | — | 0.303 | 0.145 | 0.077 |
Prepaid Expenses | |||||
Total Current Assets | 0.747 | 10.7 | 11.8 | 7.56 | 10.2 |
Other Long Term Assets | |||||
Total Assets | 0.747 | 11.3 | 12 | 7.57 | 10.2 |
Accounts Payable | |||||
Payable / Accrued | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 1.69 | 2.15 | 3.27 | 4.94 | 3.83 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Liabilities | 4.08 | 2.15 | 3.51 | 7.09 | 6.52 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | -3.34 | 9.18 | 8.51 | 0.478 | 3.63 |
Total Liabilities & Shareholders' Equity | 0.747 | 11.3 | 12 | 7.57 | 10.2 |
Total Common Shares Outstanding |